Axsome Therapeutics, Inc.
AXSM
$111.91
$1.251.13%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -9.21% | -18.34% | -21.42% | -27.79% | 34.45% |
| Total Receivables | 59.12% | 49.76% | 58.26% | 78.52% | 126.45% |
| Inventory | 4.72% | 3.94% | 42.86% | 64.50% | 96.26% |
| Prepaid Expenses | 33.04% | 47.60% | 97.25% | 99.76% | 131.34% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 7.41% | -3.81% | -6.38% | -10.90% | 51.25% |
|
|
|||||
| Total Current Assets | 7.41% | -3.81% | -6.38% | -10.90% | 51.25% |
| Net Property, Plant & Equipment | 233.20% | -21.67% | -20.23% | -16.61% | 792.83% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 16.80% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 16.80% |
| Total Other Intangibles | -12.33% | -12.00% | -11.64% | -11.32% | -11.00% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 44.34% | 68.05% | 8.99% | 6.51% | -8.03% |
| Total Assets | 9.33% | -3.36% | -6.56% | -10.37% | 40.23% |
|
|
|||||
| Total Accounts Payable | 59.24% | 76.99% | 120.82% | 42.79% | 50.38% |
| Total Accrued Expenses | 78.38% | 60.89% | 53.47% | 76.92% | 39.66% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 27.17% | 156.99% | 563.70% | 647.43% | 1,552.78% |
| Total Finance Division Other Current Liabilities | 49.69% | 44.30% | 29.26% | 11.01% | 6.47% |
| Total Other Current Liabilities | 49.69% | 44.30% | 29.26% | 11.01% | 6.47% |
| Total Current Liabilities | 69.33% | 65.72% | 71.10% | 62.27% | 43.11% |
|
|
|||||
| Total Current Liabilities | 69.33% | 65.72% | 71.10% | 62.27% | 43.11% |
| Long-Term Debt | 1.50% | 1.48% | 1.44% | 1.42% | 21.05% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 208.04% | 27.78% | 22.10% | 30.69% | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 29.41% | 25.08% | 163.01% | 107.82% | 140.55% |
| Total Liabilities | 35.29% | 28.75% | 41.41% | 33.81% | 44.82% |
|
|
|||||
| Common Stock & APIC | 17.89% | 14.93% | 13.35% | 13.91% | 45.68% |
| Retained Earnings | -30.78% | -34.37% | -42.20% | -45.73% | -48.78% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -63.06% | -70.15% | -65.53% | -63.11% | 28.82% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -63.06% | -70.15% | -65.53% | -63.11% | 28.82% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -63.06% | -70.15% | -65.53% | -63.11% | 28.82% |
|
|
|||||